Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Oric Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 152
- +10 vs. Q2 2025
- Shares held
- 106.5M
- +13.1M (+14.1%) vs. Q2 2025
- Total value
- $1.28B
- +$330.3M (+34.8%) vs. Q2 2025
- New holders
- 32
- 58 more added
- Sold out
- 22
- 34 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 182 | $1.51B |
| Q4 2025 | 165 | $979.6M |
| Q3 2025 | 152 | $1.28B |
| Q2 2025 | 142 | $947.6M |
| Q1 2025 | 143 | $442.0M |
| Q4 2024 | 129 | $611.7M |
| Q3 2024 | 122 | $715.1M |
| Q2 2024 | 113 | $478.3M |
| Q1 2024 | 112 | $879.3M |
| Q4 2023 | 92 | $465.9M |
| Q3 2023 | 90 | $290.7M |
| Q2 2023 | 83 | $353.4M |
| Q1 2023 | 71 | $188.5M |
| Q4 2022 | 64 | $192.1M |
| Q3 2022 | 76 | $104.6M |
| Q2 2022 | 83 | $147.1M |
| Q1 2022 | 101 | $181.7M |
| Q4 2021 | 80 | $512.1M |
| Q3 2021 | 82 | $762.1M |
| Q2 2021 | 78 | $639.4M |
| Q1 2021 | 82 | $874.3M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Oric Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Driehaus Capital Management LLC | 148,778 | $1.79M | 0.01% | +148,778 | New |
| Wellington Management Group LLP | 150,594 | $1.81M | 0.00% | −72,708−32.6% | Reduced |
| TD Asset Management Inc | 151,700 | $1.82M | 0.00% | −26,000−14.6% | Reduced |
| StemPoint Capital LP | 166,461 | $2.00M | 0.40% | −34,324−17.1% | Reduced |
| Resolute Capital Asset Partners LLC | 167,515 | $2.01M | 1.05% | −60,000−26.4% | Reduced |
| AQR Capital Management LLC | 171,925 | $2.06M | 0.00% | +492+0.3% | Added |
| Bank of New York Mellon Corp | 175,714 | $2.11M | 0.00% | +40,680+30.1% | Added |
| Barclays PLC | 184,091 | $2.21M | 0.00% | +41,410+29.0% | Added |
| Nicholas Investment Partners, LP | 220,735 | $2.65M | 0.20% | +146,493+197.3% | Added |
| BNP Paribas Arbitrage, SA | 238,620 | $2.86M | 0.00% | +151,865+175.1% | Added |
| Woodline Partners LP | 246,534 | $2.96M | 0.01% | +2,166+0.9% | Added |
| Sectoral Asset Management Inc | 328,655 | $3.94M | 2.43% | +97,170+42.0% | Added |
| UBS Group AG | 339,236 | $4.07M | 0.00% | +240,230+242.6% | Added |
| Sphera Funds Management Ltd. | 431,693 | $5.18M | 1.23% | +37,000+9.4% | Added |
| Adage Capital Partners GP, L.L.C. | 447,366 | $5.37M | 0.01% | +81,966+22.4% | Added |
| Polar Capital Holdings Plc | 468,610 | $5.62M | 0.03% | +468,610 | New |
| Charles Schwab Investment Management Inc | 603,207 | $7.24M | 0.00% | +220,818+57.7% | Added |
| Morgan Stanley | 745,528 | $8.95M | 0.00% | +350,743+88.8% | Added |
| Dimensional Fund Advisors LP | 793,871 | $9.52M | 0.00% | +79,005+11.1% | Added |
| Northern Trust Corp | 888,535 | $10.7M | 0.00% | +487,581+121.6% | Added |
| Integral Health Asset Management, LLC | 900,000 | $10.8M | 0.79% | −350,000−28.0% | Reduced |
| Goldman Sachs Group Inc | 904,812 | $10.9M | 0.00% | +415,175+84.8% | Added |
| Eventide Asset Management, LLC | 951,507 | $11.4M | 0.19% | +740.0% | Added |
| Euclidean Capital LLC | 989,410 | $11.9M | 4.99% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,007,575 | $12.1M | 0.47% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 1,097,497 | $13.2M | 0.24% | −180,957−14.2% | Reduced |
| Franklin Resources Inc | 1,181,329 | $14.2M | 0.00% | +138,771+13.3% | Added |
| Citadel Advisors LLC | 1,198,004 | $14.4M | 0.01% | −204,764−14.6% | Reduced |
| JPMorgan Chase & Co | 1,228,528 | $14.7M | 0.00% | −106,920−8.0% | Reduced |
| Royce & Associates LP | 1,458,483 | $17.5M | 0.17% | +1,223,709+521.2% | Added |
| Balyasny Asset Management LLC | 1,519,314 | $18.2M | 0.04% | −258,430−14.5% | Reduced |
| Geode Capital Management, LLC | 1,630,744 | $19.6M | 0.00% | +522,284+47.1% | Added |
| MPM Oncology Impact Management LP | 1,729,378 | $20.8M | 3.40% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,948,808 | $23.4M | 3.39% | +147,979+8.2% | Added |
| First Turn Management, LLC | 2,159,474 | $25.9M | 3.89% | +149,551+7.4% | Added |
| State Street Corp | 2,403,939 | $28.8M | 0.00% | +771,823+47.3% | Added |
| FMR LLC | 2,528,048 | $30.3M | 0.00% | +57,991+2.3% | Added |
| Point72 Asset Management, L.P. | 2,619,914 | $31.4M | 0.07% | −230,727−8.1% | Reduced |
| Price T Rowe Associates Inc | 2,871,327 | $34.5M | 0.00% | +108,412+3.9% | Added |
| Vivo Capital, LLC | 3,126,604 | $37.5M | 3.02% | 00.0% | Unchanged |
| The Column Group LLC | 3,540,777 | $42.5M | 52.48% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,641,756 | $43.7M | 1.05% | +2,742,475+305.0% | Added |
| NEA Management Company, LLC | 4,118,621 | $49.4M | 2.71% | 00.0% | Unchanged |
| Alkeon Capital Management LLC | 4,504,096 | $54.0M | 0.24% | 00.0% | Unchanged |
| Sr One Capital Management, LP | 4,514,929 | $54.2M | 7.84% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,650,138 | $55.8M | 0.00% | +1,525,445+48.8% | Added |
| BlackRock, Inc. | 5,276,620 | $63.3M | 0.00% | +1,198,635+29.4% | Added |
| Pfizer Inc | 5,376,344 | $64.5M | 14.75% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 6,572,700 | $78.9M | 0.20% | 00.0% | Unchanged |
| VR Adviser, LLC | 6,596,885 | $79.2M | 4.46% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 6,728,116 | $80.7M | 3.88% | +5,110,048+315.8% | Added |
| Nextech Invest, Ltd. | 7,162,637 | $86.0M | 13.08% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −1,065,334−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −485,629−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −102,583−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −76,447−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −76,286−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −49,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −38,864−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −33,530−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −22,987−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −20,892−100.0% | Sold out |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,332−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −14,286−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −12,950−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −12,728−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −11,868−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −4,836−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −3,980−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −984−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −922−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |